Diabetes Care for Breast Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Breast CancerPreDiabetesType 2 Diabetes
Interventions
BEHAVIORAL

Nurse-practitioner led intervention

"* Face-to-face or virtual consultation with NP during chemotherapy infusion with individualized recommendations/medications AND patient education through the Patient Activated Learning System (PALS).~* Weekly follow-ups from NP via phone, Zoom, or in-person (patient directed) for 12 weeks/course of chemotherapy."

Trial Locations (3)

10021

RECRUITING

Weill Cornell Medicine, New York

11215

RECRUITING

NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn

11355

RECRUITING

New York-Presbyterian Queens, Flushing

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT05565534 - Diabetes Care for Breast Cancer Patients | Biotech Hunter | Biotech Hunter